» Articles » PMID: 34797838

Changes in SARS-CoV-2 Viral Load and Mortality During the Initial Wave of the Pandemic in New York City

Abstract

Public health interventions such as social distancing and mask wearing decrease the incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but it is unclear whether they decrease the viral load of infected patients and whether changes in viral load impact mortality from coronavirus disease 2019 (COVID-19). We evaluated 6923 patients with COVID-19 at six New York City hospitals from March 15-May 14, 2020, corresponding with the implementation of public health interventions in March. We assessed changes in cycle threshold (CT) values from reverse transcription-polymerase chain reaction tests and in-hospital mortality and modeled the impact of viral load on mortality. Mean CT values increased between March and May, with the proportion of patients with high viral load decreasing from 47.7% to 7.8%. In-hospital mortality increased from 14.9% in March to 28.4% in early April, and then decreased to 8.7% by May. Patients with high viral loads had increased mortality compared to those with low viral loads (adjusted odds ratio 2.34). If viral load had not declined, an estimated 69 additional deaths would have occurred (5.8% higher mortality). SARS-CoV-2 viral load steadily declined among hospitalized patients in the setting of public health interventions, and this correlated with decreases in mortality.

Citing Articles

Long-term trends in cycle threshold values: a comprehensive analysis of COVID-19 dynamics, viral load, and reproduction number in South Korea.

Park J, Cho S, Kang S, Kim J, Jung S, Lee S Front Public Health. 2024; 12:1394565.

PMID: 39188798 PMC: 11345234. DOI: 10.3389/fpubh.2024.1394565.


Comparison of the performance of two real-time fluorescent quantitative PCR kits for the detection of SARS-CoV-2 nucleic acid: a study based on large real clinical samples.

Wang Y, Li X, Wang Y, Tu Z, Xu J, Pan J Virol J. 2022; 19(1):191.

PMID: 36401275 PMC: 9675236. DOI: 10.1186/s12985-022-01922-y.


Beyond GWAS-Could Genetic Differentiation within the Allograft Rejection Pathway Shape Natural Immunity to COVID-19?.

Szyda J, Dobosz P, Stojak J, Sypniewski M, Suchocki T, Kotlarz K Int J Mol Sci. 2022; 23(11).

PMID: 35682950 PMC: 9181155. DOI: 10.3390/ijms23116272.

References
1.
Walensky R, Walke H, Fauci A . SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities. JAMA. 2021; 325(11):1037-1038. PMC: 9009864. DOI: 10.1001/jama.2021.2294. View

2.
Zacharioudakis I, Prasad P, Zervou F, Basu A, Inglima K, Weisenberg S . Association of SARS-CoV-2 Genomic Load with Outcomes in Patients with COVID-19. Ann Am Thorac Soc. 2020; 18(5):900-903. PMC: 8086542. DOI: 10.1513/AnnalsATS.202008-931RL. View

3.
Badr H, Du H, Marshall M, Dong E, Squire M, Gardner L . Association between mobility patterns and COVID-19 transmission in the USA: a mathematical modelling study. Lancet Infect Dis. 2020; 20(11):1247-1254. PMC: 7329287. DOI: 10.1016/S1473-3099(20)30553-3. View

4.
Asch D, Sheils N, Nazmul Islam M, Chen Y, Werner R, Buresh J . Variation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the First 6 Months of the Pandemic. JAMA Intern Med. 2020; 181(4):471-478. PMC: 7756246. DOI: 10.1001/jamainternmed.2020.8193. View

5.
Smithgall M, Scherberkova I, Whittier S, Green D . Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2. J Clin Virol. 2020; 128:104428. PMC: 7217789. DOI: 10.1016/j.jcv.2020.104428. View